Amrutanjan Health Care · NSE: AMRUTANJAN · BSE: 590006
Q3 FY22 results · Oct–Dec 2021
Amrutanjan Health Care reported revenue from operations of ₹110.70 crore (up 10.6% from Q3 FY21) and net profit of ₹20.58 crore (down 1.9% from Q3 FY21) for Q3 FY22 (Oct–Dec 2021), on a standalone basis.
| Item | Q3 FY22 | Q3 FY21 | YoY | Q2 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 110.70 | 100.10 | +10.6% | 110.38 | +0.3% |
| Other income | 3.20 | 2.54 | +25.7% | 4.29 | −25.4% |
| Total income | 113.89 | 102.64 | +11.0% | 114.67 | −0.7% |
| Profit before tax | 27.91 | 28.14 | −0.8% | 26.36 | +5.9% |
| Net profit for the period | 20.58 | 20.99 | −1.9% | 19.85 | +3.7% |
| EPS, basic (₹) | 7.05 | 7.18 | −1.8% | 6.79 | +3.8% |
| Net margin (%) | 18.6 | 21.0 | 18.0 |
Standalone
- Filed with BSE
- 12 Feb 2022, 15:10 IST
- Board meeting
- 11 Feb 2022
- Period
- 01 Oct 2021 to 31 Dec 2021
- Review status
- Unaudited
- Source
- XBRL filing on BSE